Cargando…
Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment
SIMPLE SUMMARY: In the field of non-small cell lung cancer (NSCLC), there have been significant advancements in genomic data and bioinformatics tools, which have improved early diagnosis, treatment, and follow-up using biomarkers. Biomarkers provide measurable indicators of disease characteristics a...
Autores principales: | Restrepo, Juan Carlos, Dueñas, Diana, Corredor, Zuray, Liscano, Yamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340640/ https://www.ncbi.nlm.nih.gov/pubmed/37444584 http://dx.doi.org/10.3390/cancers15133474 |
Ejemplares similares
-
Coinfections and Superinfections Associated with COVID-19 in Colombia: A Narrative Review
por: Dueñas, Diana, et al.
Publicado: (2023) -
Precision medicine revolutionizes cancer diagnosis and treatment
por: Han, Chuanhui, et al.
Publicado: (2023) -
Genome editing is revolutionizing biology
por: Qi, Yiping
Publicado: (2017) -
Advances in vaccines: revolutionizing disease prevention
por: Tripathi, Timir
Publicado: (2023) -
Revolutionizing Cancer Treatment: Harnessing the Power of Biomarkers to Improve Patient Outcomes
por: Moore, Donald C., et al.
Publicado: (2023)